Search Results

You searched for : anti-CD3

	Nasal Immunotherapy Shows Promise in Reducing Inflammation and Boosting Cognitive Function in Alzheimer's Disease The discovery of nasal immunotherapy with anti-CD3 as a potential treatment for Alzheimer's disease represents a ray of hope for the millions of ... Sep 15
	Precision BioSciences and Tiziana Life Sciences announce exclusive license agreement to evaluate Foralumab Latest pharma Update... Sep 06
	Bristol Myers Squibb Receives Positive CHMP Opinion for Anti-BCMA CAR T Cell Therapy Abecma for Relapsed and Refractory Multiple Myeloma ... Jun 25
	Teneobio received US FDA clearance of investigational new drug application and the initiation of phase I clinical studies in patients with B-cell malignancies TNB-486 induced T-cell dependent killing of CD19-positive B-cell leukemia and lymphoma cells while inducing minimal cytokine secretion... Oct 05
	Sorrento Secures Exclusive License From Mayo Clinic for Antibody-Drug Antibody-Drug-Nanoparticle Albumin-Bound Immune Complex (ADNIC) platform exclusive license from Sorento... Sep 15
	AGC Biologics completes PPQ manufacturing campaign with Provention Bio for , Teplizumab Teplizumab, Provention Bioâ€™s lead drug candidate, is an anti-CD3 monoclonal antibody (mAb) being developed for the delay or prevention of type 1 diabetes ... Aug 29
	FDA approves GSKâ€™s BLENREP (belantamab mafodotin) for myleoma FDA approves GSKâ€™s BLENREP (belantamab mafodotin-blmf) for the treatment of patients with relapsed or refractory multiple myeloma... Aug 07
	EU approves Bristol Myers Squibbâ€™s Idecabtagene Vicleucel and CC-486 Finally Bristol Myers Squib receives approval from EU for Idecabtagene Vicleucel... May 23
8 Matching result(s) found!

-Advertisements-

Trending Now
	The Role of Genetic Profiles in Alzheimer’s Therapy: APOE4 and Treatment ResponsesMay 08, 2024
	Assessing Covishield Safety: Indian Research Offers Reassurance Amidst Rare Side Effect DiscussionsMay 08, 2024
	Quadria Capital Invests $102 Million in NephroPlus to Boost Dialysis Services Across AsiaMay 08, 2024
	When Your Body Makes Beer: Exploring the Curious Case of Auto-Brewery SyndromeMay 07, 2024
	Hair Today, Gone Tomorrow: Why Guys Go Bald Before Marriage May 07, 2024
	Menopausal Transitions and Mental Health: UCL Study Highlights Increased Depression RiskMay 07, 2024
	Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
	Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
	Harnessing AI for Early Alzheimer's Disease Diagnosis: IIT Indore's BreakthroughMay 06, 2024
	Aurobindo Pharma's Bhiwadi Facility Under FDA Scrutiny: Understanding the ObservationsMay 06, 2024
	Exploring the Role of Mediator Protein Complex in Cell Division: Implications for Disease ManagementMay 06, 2024
	Akshay Tritiya Parna Mahotsav is to be held in the cityMay 04, 2024
	Bharti Singh's Battle with Gallstones: Symptoms, Precautions, and Natural RemediesMay 04, 2024
	Empowering Women's Health: New Mammogram GuidelinesMay 04, 2024
	Rising Temperatures, Rising Risks: Addressing the Challenges of Heat StressMay 04, 2024
	Gynoveda, India's First Ayurveda Fertility Company, Expands Reach with New Clinic in Pune, Set to Open 100 Clinics Across India by 2027May 03, 2024
	Aptus Value Housing Finance India Limited, a leading Housing Finance Company has declared its financial results for the year ended March 31, 2024. FY 24 ResultsMay 03, 2024
	TIPS FOR PREGNANCY CARE DURING SUMMERMay 03, 2024
	The deadly intersection: TB and tobacco smoking co-epidemics in Indonesia Dr TARA SINGH BAM – CNSMay 03, 2024
	Mintoak Expands Global Footprint with Strategic Leadership AppointmentsMay 03, 2024

Search Results

Nasal Immunotherapy Shows Promise in Reducing Inflammation and Boosting Cognitive Function in Alzheimer's Disease

Precision BioSciences and Tiziana Life Sciences announce exclusive license agreement to evaluate Foralumab

Bristol Myers Squibb Receives Positive CHMP Opinion for Anti-BCMA CAR T Cell Therapy Abecma for Relapsed and Refractory Multiple Myeloma

Teneobio received US FDA clearance of investigational new drug application and the initiation of phase I clinical studies in patients with B-cell malignancies

Sorrento Secures Exclusive License From Mayo Clinic for Antibody-Drug

AGC Biologics completes PPQ manufacturing campaign with Provention Bio for , Teplizumab

FDA approves GSKâ€™s BLENREP (belantamab mafodotin) for myleoma

EU approves Bristol Myers Squibbâ€™s Idecabtagene Vicleucel and CC-486

Trending Now